For overweight or obese older women with rheumatoid arthritis, eating only during a limited window each day can reduce joint pain, swelling, and inflammation, and these benefits can last for several months after stopping the diet.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review could determine whether intermittent fasting consistently reduces DAS-28 and CRP in EORA across multiple RCTs.
A systematic review and meta-analysis of all RCTs enrolling adults aged 65+ with confirmed EORA, comparing any form of intermittent fasting (e.g., 16:8, 5:2) vs. ad libitum eating for ≥12 weeks, with primary outcomes: change in DAS-28, CRP, and body weight.
An RCT could determine whether intermittent fasting directly reduces disease activity in EORA compared to standard eating patterns.
A double-blind, parallel-group RCT of 100 adults aged 65+ with EORA and BMI ≥27, randomized to time-restricted eating (eating window 12:00–8:00 PM) vs. three meals/day without time restriction for 24 weeks, with primary outcome: change in DAS-28 and serum IL-6.
A prospective cohort could show whether habitual intermittent fasting predicts slower disease progression in EORA.
A prospective cohort study following 250 adults aged 65+ with RA, classifying dietary patterns as intermittent fasting (≥3 days/week) vs. regular eating, and tracking DAS-28, CRP, and joint damage annually for 5 years.
A cross-sectional study could confirm the association between fasting patterns and inflammatory markers in EORA.
A cross-sectional study comparing DAS-28, CRP, and fasting insulin levels in 120 EORA patients who practice intermittent fasting (≥6 months) vs. 120 who do not, matched for age, BMI, and medication.
A case series could document individual responses to fasting in EORA patients with marked microbiota shifts.
A case series of 8 EORA patients who initiate intermittent fasting, collecting stool samples, CRP, and DAS-28 before, at 8 weeks, and at 6 months after initiation.